Today we are excited to announce that we are joining forces with PicnicHealth, a company that shares our vision of putting patients at the core of research. PicnicHealth and AllStripes’ patient-centric model enables a deeper view of each patient's health while reducing the challenges of traditional site-based studies. By joining forces, we’ll continue the work of harnessing the power of patient data to shape the future of evidence generation. From the bottom of our hearts; thank you to all our partners and supporters for being a part of our journey and our important mission. We are excited to continue our work within PicnicHealth to put patients at the center of research. Read the full announcement here: https://lnkd.in/eU2MwURC
AllStripes
Biotechnology Research
San Francisco, California 6,033 followers
Unlocking new treatments for people with rare disease
Über uns
AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. AllStripes has developed a technology platform that generates regulatory-ready evidence to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to securely participate in treatment research online and benefit from their own medical data. AllStripes was founded by CEO Nancy Yu and technology developer Onno Faber, following his diagnosis and journey with the rare disease neurofibromatosis type 2. The company is backed by Lux Capital, JAZZ Venture Partners, Spark Capital, Medidata Solutions, McKesson Ventures, Maveron, and a number of angel investors. For more information, visit www.allstripes.com.
- Website
-
http://allstripes.com
External link for AllStripes
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 51-200 Mitarbeiter
- Hauptsitz
- San Francisco, Kalifornien
- Typ
- In Privatbesitz
- Gegründet
- 2017
- Spezialitäten
- rare disease
Standorte
-
Primäre
Wegbeschreibung erhalten
121 2nd St
San Francisco, Kalifornien 94105, US